Diagnostics

Cleara Biotech Raises $2.5M to Advance Cancer Drugs Targeting 'Scarred Cell' Biomarkers

Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers

Tavros Therapeutics Raises $7.5M to Advance Biomarker-Directed Cancer Drug Discovery Platform

Myongji Hospital, Next&Bio Partner on Organoid-Based Precision Therapy Program

Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform

Revolution Medicines Begins Phase I Trial of KRAS G12C Inhibitor

Immunitas Cleared by FDA to Begin Trial of IMT-009 in Hematologic Malignancies, Solid Tumors

Merck KGaA, Nerviano Enter License Agreement for PARP1 Inhibitor NMS-293

Abpro Licenses HER2-Targeteing Bispecific Antibody to Celltrion

Liquid Biopsy Firm Hedera Dx Raises €14M in Seed Funding

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib

Elicio Receives $2.8M Grant for Cancer Vaccine Development

Verismo Therapeutics to Begin Phase I Trial of Autologous Cell Therapy SynKIR-110

ImmunoScape Raises $14M

Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests

Biocytogen Pharmaceuticals, Guangzhou FineImmune Biotechnology Ink Cell Therapy Partnership